Over 90 Total Lots Up For Auction at One Location - WA 04/08

Zimmer Biomet unveils clinical services suite called Signature Solutions

Press releases may be edited for formatting or style | July 26, 2016
(WARSAW, IN) July 26, 2016—Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today unveiled Signature Solutions™, a comprehensive suite of clinical services and technologies designed to assist hospitals and medical practices to seamlessly transition to value-based healthcare models by maintaining excellent patient outcomes, while maximizing procedural and cost efficiencies across the entire episode of care. Last year alone, the U.S. launched two major value-based healthcare mandates, the Comprehensive Care for Joint Replacement (CJR) act and the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), and Europe and Canada have been actively passing similar policies that base reimbursement on patient and health economic outcomes.

Signature Solutions had its genesis in the mid-1990s, when Zimmer Biomet launched its expert consulting services in response to the evolving global shift toward value-based healthcare. Since then, the Company has advised more than 450 hospitals and healthcare facilities worldwide on improving the value of their musculoskeletal programs by providing better care, lowering costs and increasing the number of patients treated. Signature Solutions will integrate Zimmer Biomet's established consulting platform, with a strategically curated suite of technologies and services, to form a one-of-a-kind offering that drives improvement across every aspect of the healthcare value creation equation. Initially, Zimmer Biomet will offer the comprehensive suite of solutions to musculoskeletal healthcare service lines at select, academic facilities in the U.S., with a broader release scheduled for 2017.

"Our 90-year legacy and leadership in musculoskeletal healthcare, coupled with more than a decade of consulting experience delivering measurably improved outcomes for large and small institutions worldwide, gives Zimmer Biomet a deep understanding of the levers driving success in the value-based healthcare environment," said David Dvorak, President and CEO of Zimmer Biomet. "Signature Solutions will encapsulate our exclusive and extensive knowledge of the new healthcare landscape into the first end-to-end suite of clinical services, technologies and proprietary analytical tools, which are designed to work seamlessly with the institutions' existing infrastructure to improve quality outcomes, provide more efficient care and increase provider throughput."

You Must Be Logged In To Post A Comment